Corcept Therapeutics (CORT) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to -$5.2 million.
- Corcept Therapeutics' Other Gross PP&E Adjustments rose 626.93% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year increase of 626.93%. This contributed to the annual value of -$6.7 million for FY2024, which is 16610.91% down from last year.
- Per Corcept Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$5.2 million for Q3 2025, which was up 626.93% from -$5.3 million recorded in Q2 2025.
- Corcept Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $3.7 million for Q2 2023, and its period low was -$6.7 million during Q4 2024.
- Over the past 5 years, Corcept Therapeutics' median Other Gross PP&E Adjustments value was $609000.0 (recorded in 2022), while the average stood at -$1.1 million.
- In the last 5 years, Corcept Therapeutics' Other Gross PP&E Adjustments soared by 80642.2% in 2021 and then tumbled by 69557.52% in 2025.
- Over the past 5 years, Corcept Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $1.3 million in 2021, then fell by 28.8% to $932000.0 in 2022, then crashed by 369.42% to -$2.5 million in 2023, then crashed by 166.11% to -$6.7 million in 2024, then rose by 22.81% to -$5.2 million in 2025.
- Its Other Gross PP&E Adjustments was -$5.2 million in Q3 2025, compared to -$5.3 million in Q2 2025 and -$5.4 million in Q1 2025.